Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
SAXENDA was evaluated for safety in 5 double-blind, placebo controlled trials that included 3,384 overweight or obese adult patients treated with SAXENDA for a treatment period up to 56 weeks (3 trials), 52 weeks (1 trial), and 32 weeks (1 trial) and one trial of 56 weeks in 125 pediatric patients with obesity aged 12 years and older [see Clinical Studies (14.1, 14.2)]
Highmark will follow up with us regularly with a list of groups that have paid OR continue to be delinquent
Microdose tirzepatide applies the same lower-dose philosophy to a dual GLP-1/GIP medication pathway
The specific dose depends on your baseline B12 level, dietary sources, and how long you plan to continue semaglutide therapy
treating a smaller area like the skin around your eyes will naturally cost less than a larger area like your abdomen
US$ 23.87
US$ 28.14
US$ 23.69
